Controlling Lung Tumors with Immune Cells
Author Information
Author(s): Oflazoglu Ezogelin, Elliott Mark, Takita Hiroshi, Ferrone Soldano, Henderson Robert A, Repasky Elizabeth A
Primary Institution: Roswell Park Cancer Institute
Hypothesis
Can adoptively transferred human lung tumor specific cytotoxic T cells control autologous tumor growth in a SCID mouse model?
Conclusion
The study shows that tumor antigen-specific CTLs can effectively suppress the growth of lung tumors in a mouse model.
Supporting Evidence
- The CTLs were found to have an activated memory phenotype.
- A single injection of CTLs provided significant but temporary control of tumor growth.
- CTLs were capable of homing to and killing autologous tumors in vivo.
- Surviving tumor cells expressed reduced MHC class I antigens after CTL treatment.
Takeaway
Scientists found that special immune cells from lung cancer patients can help fight their own tumors when tested in mice.
Methodology
The study used a SCID mouse model to test the effects of adoptively transferred CTLs on lung tumors derived from the same patient.
Limitations
The study is based on a single patient's tumor, which may limit the generalizability of the findings.
Participant Demographics
The study involved a single patient with lung cancer.
Statistical Information
P-Value
<0.001
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website